Cargando…

Clinical and economic evaluations of natalizumab, rituximab, and ocrelizumab for the management of relapsing-remitting multiple sclerosis in Saudi Arabia

INTRODUCTION: The advent of new disease-modifying therapies (DMTs), such as monoclonal antibodies (mAbs), resulted in significant changes in the treatment guidelines for Multiple sclerosis (MS) and improvement in the clinical outcomes. However, mAbs, such as rituximab, natalizumab, and ocrelizumab,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alharbi, Mansour A., Aldosari, Fahad, Althobaiti, Ahmed Hasan, Abdullah, Faris M., Aljarallah, Salman, Alkhawajah, Nuha M., Alanazi, Miteb, AlRuthia, Yazed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223862/ https://www.ncbi.nlm.nih.gov/pubmed/37237257 http://dx.doi.org/10.1186/s12913-023-09462-z

Ejemplares similares

Real-World Comparative Cost-Effectiveness Analysis of Different Classes of Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2021)

Drug-drug interactions and pharmacists’ interventions among psychiatric patients in outpatient clinics of a teaching hospital in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2019)

Predictors of Opioid Prescription Among a Sample of Patients with Acute Musculoskeletal Pain at a Tertiary Care Hospital in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2020)

Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients
por: van Lierop, ZYGJ, et al.
Publicado: (2021)

Cost effectiveness of rivaroxaban versus warfarin among nonvalvular atrial fibrillation patients in Saudi Arabia: A Single–Center retrospective cohort study
por: AlRuthia, Yazed, et al.
Publicado: (2023)

2020 Update to Spinal Muscular Atrophy Management in Saudi Arabia
por: Bashiri, Fahad A., et al.
Publicado: (2021)

Assessment of factors associated with depression and anxiety among pwMS in Saudi Arabia
por: AlSaeed, Safanah, et al.
Publicado: (2022)

Pharmacy students’ attitudes toward patient safety in Saudi Arabia: a cross-sectional study
por: Alwhaibi, Monira, et al.
Publicado: (2020)

The cost-effectiveness of sequential versus standard triple therapy for Helicobacter pylori eradication in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2021)

Cost-effectiveness analysis of rituximab versus natalizumab in patients with relapsing remitting multiple sclerosis
por: Rezaee, Mehdi, et al.
Publicado: (2022)

Assessing the pharmacy students’ knowledge of common medical terms after a curricular change in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2020)

The Prevalence of High-Risk Prescribing of Oral Non-Steroidal Anti-Inflammatory Drugs in Primary Healthcare: A Single-Centre Retrospective Chart Review Study
por: Assiri, Ghadah Asaad, et al.
Publicado: (2022)

Unmet Needs and Treatment of Relapsing-Remitting Multiple Sclerosis in Saudi Arabia: Focus on the Role of Ofatumumab
por: Craner, Matthew, et al.
Publicado: (2022)

Alemtuzumab/natalizumab/ocrelizumab: COVID-19: 3 case reports
Publicado: (2021)

The impact of Hydroxyurea on the rates of Vaso–occlusive crises in patients with sickle cell disease in Saudi Arabia: a single–center study
por: Alkhalifah, Sahar Abdullah, et al.
Publicado: (2022)

Endocarditis following ocrelizumab in relapsing-remitting MS
por: Faissner, Simon, et al.
Publicado: (2020)

Associations of Depression and Anxiety with Stigma in a Sample of Patients in Saudi Arabia Who Recovered from COVID-19
por: Alkathiri, Munirah A, et al.
Publicado: (2022)

The Commonly Utilized Natural Products during the COVID-19 Pandemic in Saudi Arabia: A Cross-Sectional Online Survey
por: AlNajrany, Sina M., et al.
Publicado: (2021)

Disease Evolution in Women With Highly Active MS Who Suspended Natalizumab During Pregnancy vs Rituximab/Ocrelizumab Before Conception
por: Demortiere, Sarah, et al.
Publicado: (2023)

How can Saudi Arabia reform its public hospital payment models? A narrative review
por: AlRuthia, Yazed, et al.
Publicado: (2020)

Effect of Rituximab Compared with Natalizumab and Fingolimod in Patients with Relapsing–Remitting Multiple Sclerosis: A Cohort Study
por: Hernández-Preciado, Martha Rocio, et al.
Publicado: (2022)

Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab
por: Toorop, Alyssa A., et al.
Publicado: (2020)

Restless leg syndrome in multiple sclerosis: a case–control study
por: Aljarallah, Salman, et al.
Publicado: (2023)

The status of licensed pharmacy workforce in Saudi Arabia: a 2030 economic vision perspective
por: AlRuthia, Yazed, et al.
Publicado: (2018)

A Model-Based Economic Evaluation of Cladribine Versus Alemtuzumab, Ocrelizumab and Natalizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis with High Disease Activity in Chile
por: Espinoza, Manuel Antonio, et al.
Publicado: (2021)

Rate and risk factors of postoperative endoscopic recurrence of moderate- to high-risk Crohn's disease patients - A real-world experience from a Middle Eastern cohort
por: Azzam, Nahla, et al.
Publicado: (2022)

Proxy-Reported Quality of Life and Access to Nusinersen Among Patients with Spinal Muscular Atrophy in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2021)

Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis: an observational study
por: Bigaut, Kévin, et al.
Publicado: (2022)

Medical Faculty’s and Students’ Perceptions toward Pediatric Electronic OSCE during the COVID-19 Pandemic in Saudi Arabia
por: Shaiba, Lana A., et al.
Publicado: (2021)

The Impact of Depression and Anxiety on Adult Cancer Patients’ Health-Related Quality of Life
por: Alwhaibi, Monira, et al.
Publicado: (2023)

Anxiety and depression and health-related quality of life among adults with migraine: a National Population-Based Study
por: Alwhaibi, Monira, et al.
Publicado: (2023)

Tumefactive demyelination in a patient with relapsing-remitting MS on ocrelizumab
por: Moreira Ferreira, Vanessa F., et al.
Publicado: (2019)

Predictors of Hospitalization Among Older Adults with COVID-19 in Saudi Arabia: A Cross-Sectional Study of a Nationally Representative Sample
por: Alamri, Fahad, et al.
Publicado: (2021)

Cost-effectiveness of telemedicine care for patients with uncontrolled type 2 diabetes mellitus during the COVID-19 pandemic in Saudi Arabia
por: Faleh AlMutairi, Manal, et al.
Publicado: (2021)

Drug utilization and cost associated with inflammatory bowel disease management in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2019)

Self-Reported COVID-19 Vaccines’ Side Effects among Patients Treated with Biological Therapies in Saudi Arabia: A Multicenter Cross-Sectional Study
por: AlMutairi, Lama T, et al.
Publicado: (2022)

Health Care Applicability of a Patient-Centric Web Portal for Patients’ Medication Experience
por: Hong, Song Hee, et al.
Publicado: (2016)

Gender Differences in the Prevalence of Complementary and Alternative Medicine Utilization among Adults with Arthritis in the United States
por: Alwhaibi, Monira, et al.
Publicado: (2019)

Healthcare Expenditures Associated With Comorbid Anxiety and Depression Among Adults With Migraine
por: Alwhaibi, Monira, et al.
Publicado: (2021)

Ocrelizumab/rituximab: Various toxicities: 6 case reports
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3afdotks21q3p3ngfomhg0kiqv